215 related articles for article (PubMed ID: 16279285)
1. An agenda for clinical trials: clinical trials in the genomic era.
Simon RM
Clin Trials; 2004; 1(5):468-70. PubMed ID: 16279285
[No Abstract] [Full Text] [Related]
2. On the use of pharmacogenetics in cancer treatment and clinical trials.
Robert J; Le Morvan V; Giovannetti E; Peters GJ;
Eur J Cancer; 2014 Oct; 50(15):2532-43. PubMed ID: 25103456
[TBL] [Abstract][Full Text] [Related]
3. Genomic medicines for oncology: early lessons.
Simons JW
J Med Assoc Ga; 2003; 92(1):35-8. PubMed ID: 12743904
[No Abstract] [Full Text] [Related]
4. Utility of adaptive strategy and adaptive design for biomarker-facilitated patient selection in pharmacogenomic or pharmacogenetic clinical development program.
Wang SJ
J Formos Med Assoc; 2008 Dec; 107(12 Suppl):19-27. PubMed ID: 19129042
[TBL] [Abstract][Full Text] [Related]
5. [Individuated molecular target chemotherapy].
Yamamoto W; Endo W; Sato A; Matsukawa M
Nihon Rinsho; 2002 Jan; 60(1):168-73. PubMed ID: 11808329
[TBL] [Abstract][Full Text] [Related]
6. The impact of genomics on anti-infectives drug discovery and development.
Parkinson T
Trends Microbiol; 2002; 10(10 Suppl):S22-6. PubMed ID: 12377564
[TBL] [Abstract][Full Text] [Related]
7. Drug discovery and development in the age of molecular medicine.
Vallance P; Levick M
Clin Pharmacol Ther; 2007 Oct; 82(4):363-6. PubMed ID: 17851574
[TBL] [Abstract][Full Text] [Related]
8. Future of clinical genomics in pediatric oncology.
Janeway KA; Place AE; Kieran MW; Harris MH
J Clin Oncol; 2013 May; 31(15):1893-903. PubMed ID: 23589558
[TBL] [Abstract][Full Text] [Related]
9. A target or a demi-target.
Mok TS
Clin Lung Cancer; 2010 May; 11(3):147-8. PubMed ID: 20439189
[No Abstract] [Full Text] [Related]
10. Underrepresentation of women in clinical drug trials.
Schmucker DL; Vesell ES
Clin Pharmacol Ther; 1993 Jul; 54(1):11-5. PubMed ID: 8330458
[No Abstract] [Full Text] [Related]
11. The conduct of phase I-II clinical trials in children with cancer.
Pratt CB
Med Pediatr Oncol; 1991; 19(4):304-9. PubMed ID: 2056975
[TBL] [Abstract][Full Text] [Related]
12. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
13. Clinical trials: More trials, fewer tribulations.
Eisenstein M
Nature; 2014 May; 509(7502):S55-7. PubMed ID: 24870821
[No Abstract] [Full Text] [Related]
14. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.
Farwell MD; Clark AS; Mankoff DA
JAMA Oncol; 2015 Jul; 1(4):421-2. PubMed ID: 26181243
[No Abstract] [Full Text] [Related]
15. Genetics begets genomics: tailor-made medicine.
Harv Health Lett; 2005 Nov; 31(1):4. PubMed ID: 16353325
[No Abstract] [Full Text] [Related]
16. [Human, economics and social sciences: rebounds of ideas on genomics and clinical trials].
Julian-Reynier C
Med Sci (Paris); 2012 Mar; 28 Spec No 1():3-4. PubMed ID: 22494647
[No Abstract] [Full Text] [Related]
17. Overcoming challenges of using blood samples with gene expression microarrays to advance patient stratification in clinical trials.
McPhail S; Goralski TJ
Drug Discov Today; 2005 Nov; 10(22):1485-7. PubMed ID: 16257365
[TBL] [Abstract][Full Text] [Related]
18. In silico prediction of clinical efficacy.
Michelson S; Sehgal A; Friedrich C
Curr Opin Biotechnol; 2006 Dec; 17(6):666-70. PubMed ID: 17046236
[TBL] [Abstract][Full Text] [Related]
19. News from the Society for Women's Health Research: subgroup analysis in clinical trials: detecting sex differences.
Greenberger PE; Knab S
J Womens Health Gend Based Med; 2002; 11(1):7-9. PubMed ID: 11860718
[No Abstract] [Full Text] [Related]
20. Beyond genomics.
Dollery CT
Clin Pharmacol Ther; 2007 Oct; 82(4):366-70. PubMed ID: 17851575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
